BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 17095087)

  • 41. Hypereosinophilic syndrome in the tyrosine kinase inhibitor era.
    Takahashi N
    Intern Med; 2015; 54(6):551-2. PubMed ID: 25786442
    [No Abstract]   [Full Text] [Related]  

  • 42. FIP1L1-PDGFRA and c-kit D816V mutation-based clonality studies in systemic mast cell disease associated with eosinophilia.
    Tefferi A; Lasho TL; Brockman SR; Elliott MA; Dispenzieri A; Pardanani A
    Haematologica; 2004 Jul; 89(7):871-3. PubMed ID: 15257945
    [TBL] [Abstract][Full Text] [Related]  

  • 43. FIP1L1-PDGFRA positive chronic eosinophilic leukaemia and associated central nervous system involvement.
    Williams C; Kalra S; Nath U; Bown N; Wilson V; Wilkins BS; Neylon AJ
    J Clin Pathol; 2008 May; 61(5):677-80. PubMed ID: 18256119
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic eosinophilic leukaemia with FIP1L1-PDGFRA fusion and T6741 mutation that evolved from Langerhans cell histiocytosis with eosinophilia after chemotherapy.
    Ohnishi H; Kandabashi K; Maeda Y; Kawamura M; Watanabe T
    Br J Haematol; 2006 Sep; 134(5):547-9. PubMed ID: 16856885
    [No Abstract]   [Full Text] [Related]  

  • 45. FIP1L1-PDGFRalpha alone or with other genetic abnormalities reveals disease progression in chronic eosinophilic leukemia but good response to imatinib.
    Wang LN; Pan Q; Fu JF; Shi JY; Jin J; Li JM; Hu J; Zhao WL; Chen Z; Chen SJ
    Chin Med J (Engl); 2008 May; 121(10):867-73. PubMed ID: 18706197
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Frequent false-negative FIP1L1-PDGFRA FISH analyses of bone marrow samples from clonal eosinophilia at diagnosis.
    Olsson-Arvidsson L; Norberg A; Sjögren H; Johansson B
    Br J Haematol; 2020 Mar; 188(5):e76-e79. PubMed ID: 31854104
    [No Abstract]   [Full Text] [Related]  

  • 47. Acute lymphoblastic leukemia with eosinophilia and basophilia.
    Parker D; Graham-Pole J; Malpas JS; Paxton A
    Am J Pediatr Hematol Oncol; 1979; 1(3):195-9. PubMed ID: 295578
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Consultation for Elevated Blood Eosinophils: Clinical Presentations, High Value Diagnostic Tests, and Treatment Options.
    Khoury P; Bochner BS
    J Allergy Clin Immunol Pract; 2018; 6(5):1446-1453. PubMed ID: 30197068
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gastrointestinal Manifestations of Hypereosinophilic Syndromes and Mast Cell Disorders: a Comprehensive Review.
    Nanagas VC; Kovalszki A
    Clin Rev Allergy Immunol; 2019 Oct; 57(2):194-212. PubMed ID: 30003499
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Idiopathic hypereosinophilia is clonal disorder? Clonality identified by targeted sequencing.
    Lee JS; Seo H; Im K; Park SN; Kim SM; Lee EK; Kim JA; Lee JH; Kwon S; Kim M; Koh I; Hwang S; Park HW; Kang HR; Park KS; Kim JH; Lee DS
    PLoS One; 2017; 12(10):e0185602. PubMed ID: 29088303
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypereosinophilia in Children and Adults: A Retrospective Comparison.
    Williams KW; Ware J; Abiodun A; Holland-Thomas NC; Khoury P; Klion AD
    J Allergy Clin Immunol Pract; 2016; 4(5):941-947.e1. PubMed ID: 27130711
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CD3-CD4+ lymphoid variant of hypereosinophilic syndrome: nodal and extranodal histopathological and immunophenotypic features of a peripheral indolent clonal T-cell lymphoproliferative disorder.
    Lefèvre G; Copin MC; Roumier C; Aubert H; Avenel-Audran M; Grardel N; Poulain S; Staumont-Sallé D; Seneschal J; Salles G; Ghomari K; Terriou L; Leclech C; Morati-Hafsaoui C; Morschhauser F; Lambotte O; Ackerman F; Trauet J; Geffroy S; Dumezy F; Capron M; Roche-Lestienne C; Taieb A; Hatron PY; Dubucquoi S; Hachulla E; Prin L; Labalette M; Launay D; Preudhomme C; Kahn JE;
    Haematologica; 2015 Aug; 100(8):1086-95. PubMed ID: 25682606
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The lymphoid variant of hypereosinophilic syndrome: study of 21 patients with CD3-CD4+ aberrant T-cell phenotype.
    Lefèvre G; Copin MC; Staumont-Sallé D; Avenel-Audran M; Aubert H; Taieb A; Salles G; Maisonneuve H; Ghomari K; Ackerman F; Legrand F; Baruchel A; Launay D; Terriou L; Leclech C; Khouatra C; Morati-Hafsaoui C; Labalette M; Borie R; Cotton F; Gouellec NL; Morschhauser F; Trauet J; Roche-Lestienne C; Capron M; Hatron PY; Prin L; Kahn JE;
    Medicine (Baltimore); 2014 Oct; 93(17):255-266. PubMed ID: 25398061
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mepolizumab as a corticosteroid-sparing agent in lymphocytic variant hypereosinophilic syndrome.
    Roufosse F; de Lavareille A; Schandené L; Cogan E; Georgelas A; Wagner L; Xi L; Raffeld M; Goldman M; Gleich GJ; Klion A
    J Allergy Clin Immunol; 2010 Oct; 126(4):828-835.e3. PubMed ID: 20810155
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Primary eosinophilic disorders: a concise review.
    Pardanani A; Tefferi A
    Curr Hematol Malig Rep; 2008 Jan; 3(1):37-43. PubMed ID: 20425445
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy.
    Ogbogu PU; Bochner BS; Butterfield JH; Gleich GJ; Huss-Marp J; Kahn JE; Leiferman KM; Nutman TB; Pfab F; Ring J; Rothenberg ME; Roufosse F; Sajous MH; Sheikh J; Simon D; Simon HU; Stein ML; Wardlaw A; Weller PF; Klion AD
    J Allergy Clin Immunol; 2009 Dec; 124(6):1319-25.e3. PubMed ID: 19910029
    [TBL] [Abstract][Full Text] [Related]  

  • 57. T-cell abnormalities are present at high frequencies in patients with hypereosinophilic syndrome.
    Helbig G; Wieczorkiewicz A; Dziaczkowska-Suszek J; Majewski M; Kyrcz-Krzemien S
    Haematologica; 2009 Sep; 94(9):1236-41. PubMed ID: 19734416
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypereosinophilic syndrome variants: diagnostic and therapeutic considerations.
    Roufosse F
    Haematologica; 2009 Sep; 94(9):1188-93. PubMed ID: 19734412
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypereosinophilic syndromes.
    Roufosse FE; Goldman M; Cogan E
    Orphanet J Rare Dis; 2007 Sep; 2():37. PubMed ID: 17848188
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 'Idiopathic' eosinophilia with an Occult T-cell clone: prevalence and clinical course.
    Vaklavas C; Tefferi A; Butterfield J; Ketterling R; Verstovsek S; Kantarjian H; Pardanani A
    Leuk Res; 2007 May; 31(5):691-4. PubMed ID: 17095087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.